Peptide administration for lung fibrosis treatment using formulation based on medusa technology. develop a sustained release formulation os p144 or p17, loquid or freeze-dried form, for subcutaneous administration route and carry on preclinical and clinical trials.
The objective is to design and develop a histamine h3 receptor inverse agonist as a novel type of drug for use in the treatment of alzheimer's disease, obesity and/or epilepsy.
The fundamentals for a "natural" supply chain of fats will be developed. For this step change, chemical processes must be eliminated. This involves development of milder oil purification, application of enzymes and development of a new variety of sunflower.
Development of a natural component based on clays, diatomite and seaweeds which will replace the current growth promoters and the fight against mycotoxicosis in animal feed.
Development of new products to replace the subtherapeutic use of antibiotics and alternatives to the coccidiostatics currently used in farm livestock food.
Fundamental research to develop the basis for a very accurate innovative tool for the selection of different meat and carcass quality measurements in pork production.
Identification of the causative genes for phenotypical differences in prolificacy, through the identification of quantitative trait loci (qtl) that influence reproductive characteristics in pigs, to enable a direct selection of these genes.
A new system of imaging of cardiac viability by resonance imaging. Comparative study with other diagnostic techniques.
The aim is to develop a new artificial intervertebral disc. For that a new hydrogel-based reinforced material will be developed using new technology. The disc shall be suitable for use with a minimally invasive approach.
Aims at developing new families of molecules to be used for in vivo dna surgery, as a therapeutic approach to genetic and viral diseases, or to be used as industrial tools.